Biotechnology Regulation and GMOs
Show Less

Biotechnology Regulation and GMOs

Law, Technology and Public Contestations in Europe

  • Biotechnology Regulation series

Naveen Thayyil

This book examines the EU regulatory framework in the Genetic Modification of agriculture and food to see how adequately EU law treats serious contestations about the development and use of GMOs. Since linkages between law, technology and public contestations could have a crucial dimension in the shaping of democratic societies, the space EU law provides for publics outside of the scientific experts to shape the regulation of GMOs becomes significant. By examining the employment of the precautionary principle and (the advices from) public bioethics committees in GMO regulation, this book examines the policy claim of public participation as a mechanism to represent and mediate public contestations about the use and regulation of GMOs.
Buy Book in Print
Show Summary Details

Chapter 3: Risk, science and society

Naveen Thayyil

Extract

Protection of human health and the environment against hazards from the introduction of new technologies has long been identified as a central function of the modern welfare state. The resolution of safety concerns had become particularly important for the acceptability and feasibility of the development and application of new technologies by the 1980s. Since awareness of industrial and technological hazards had grown significantly by this time, many treated the concerns about introduction of new technologies like biotechnologies and nano-technologies as restricted only to an issue of safety. Significantly, the last three decades have seen a slow and steady change in regulatory emphasis on safety, from an investigation of hazards to a more complex regulation of risks, where risk is seen as 'replacing need as the core principle of social policy formulation'. The introductory account of EU regulation of GMOs in the previous chapter identified the pursuit of safety as the dominant trope for authorization and release of GMOs. Two motifs were further discernible, viz., the concept of risk and the principle of precaution, as central to the way concerns of safety are represented and mediated in EU regulation. This chapter seeks a conceptual focus on risk as a dominant regulatory tool to pursue the public objective of safety. The endeavour here is to understand how risk is employed in regulatory engagements with public contestations about GMOs, and the technological trajectories GMOs signify. Evidenced in our examination of the EU regulatory framework in the previous chapter, risk is currently the central organizing principle in the commercial release of GMOs.

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.


Further information

or login to access all content.